EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,128,000 | -26.8% | 36,326 | -3.3% | 0.02% | -13.6% |
| Q1 2022 | $1,542,000 | +6.4% | 37,564 | +12.7% | 0.02% | +15.8% |
| Q4 2021 | $1,449,000 | -21.4% | 33,338 | -9.5% | 0.02% | -26.9% |
| Q3 2021 | $1,844,000 | -20.1% | 36,832 | +0.5% | 0.03% | -21.2% |
| Q2 2021 | $2,309,000 | -7.2% | 36,664 | +36.9% | 0.03% | -15.4% |
| Q1 2021 | $2,487,000 | +13.1% | 26,773 | +9.1% | 0.04% | +5.4% |
| Q4 2020 | $2,198,000 | -13.2% | 24,536 | +0.1% | 0.04% | -24.5% |
| Q3 2020 | $2,532,000 | -31.9% | 24,508 | -47.9% | 0.05% | -36.4% |
| Q2 2020 | $3,717,000 | +59.0% | 47,014 | +16.3% | 0.08% | +35.1% |
| Q1 2020 | $2,338,000 | +21.2% | 40,408 | +13.0% | 0.06% | +39.0% |
| Q4 2019 | $1,929,000 | +2.4% | 35,762 | -0.8% | 0.04% | -2.4% |
| Q3 2019 | $1,884,000 | +6.2% | 36,036 | -1.8% | 0.04% | +7.7% |
| Q2 2019 | $1,774,000 | – | 36,713 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |